NCT04542382 2025-03-30
BCRPmarker
University of California, San Francisco
Phase 1 Completed
Clinical Trials
4 trialsNCT00966472 2020-04-21
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Ottawa Hospital Research Institute
Phase 1 Completed
NCT01051401 2018-08-01
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Wake Forest University Health Sciences
Phase 1 Terminated
NCT02483871 2017-06-05
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Duke University
Phase 1 Withdrawn